Amitriptyline + hydrochlorothiazide + caffeine

Amitriptyline + hydrochlorothiazide + caffeine is a hypothetical or unlisted combination of three active pharmaceutical ingredients. Amitriptyline is a tricyclic antidepressant primarily used to treat depressive disorders and certain pain conditions by inhibiting the reuptake of norepinephrine and serotonin in the central nervous system[1][6]. Hydrochlorothiazide is a thiazide diuretic commonly prescribed for hypertension and edema, acting by inhibiting sodium reabsorption in the distal tubules of the kidney, leading to increased excretion of sodium and water. Caffeine is a central nervous system stimulant that acts as an adenosine receptor antagonist, promoting wakefulness and mild diuresis. There are no known approved pharmaceutical products or brand names containing this specific triple combination; however, drug interactions between these agents have been described individually (e.g., amitriptyline with hydrochlorothiazide)[3][5]. Each component has distinct mechanisms of action.